We are live on
!
Find out more
CCM
Camber Capital Management Portfolio holdings
AUM
$1.07B
1-Year Est. Return
8.19%
This Fund
S&P 500
This Quarter
Est. Return
+5.24%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$3.25B
AUM Growth
+$336M
(+12%)
Cap. Flow
+$192M
Cap. Flow
% of AUM
5.9%
Top 10 Holdings %
Top 10 Hldgs %
66.02%
Holding
47
New
8
Increased
9
Reduced
7
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$127M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$53.2M |
| 3 |
CONMED
CNMD
|
+$31.4M |
| 4 |
Universal Health Services
UHS
|
+$31.1M |
| 5 |
GSK
GSK
|
+$29.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$95.9M |
| 2 |
Sanofi
SNY
|
+$73M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$64.9M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$64.3M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$39.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 88.91% |
| 2 | Consumer Staples | 0.6% |
| 3 | Consumer Discretionary | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUVA
26
DELISTED
NuVasive, Inc.
NUVA
| $24.8M | 0.76% |
600,000
+100,000
| +20% | +$4.28M |
|
|
ZIMV
27
DELISTED
ZimVie
ZIMV
| $23.5M | 0.72% |
3,250,000
+650,000
| +25% | +$5.54M |
|
28
Replimune Group
REPL
$1.01B
| $22.1M | 0.68% |
1,250,000
+250,000
| +25% | +$5.95M |
|
29
Glaukos
GKOS
$10.6B
| $17.5M | 0.54% |
350,000
| – | – |
|
30
Globus Medical
GMED
$11.2B
| $17.3M | 0.53% |
+305,000
| New | +$19.6M |
|
|
31
Align Technology
ALGN
$12.3B
| $16.7M | 0.51% |
50,000
-325,000
| -87% | -$95.9M |
|
|
NSTG
32
DELISTED
NanoString Technologies, Inc.
NSTG
| $14.8M | 0.46% |
1,500,000
| – | – |
|
33
Herbalife
HLF
$1.29B
| $13.3M | 0.41% |
+825,000
| New | +$14.6M |
|
34
Puma Biotechnology
PBYI
$454M
| $13.1M | 0.4% |
4,235,000
| – | – |
|
35
Inogen
INGN
$164M
| $12.2M | 0.37% |
975,000
+670,000
| +220% | +$12.8M |
|
|
BKDT
36
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
| $11.6M | 0.36% |
250,000
| – | – |
|
|
CVAC
37
DELISTED
CureVac
CVAC
| $8.71M | 0.27% |
+1,250,000
| New | +$10.9M |
|
38
Peloton Interactive
PTON
$2.49B
| $8.51M | 0.26% |
750,000
-1,250,000
| -63% | -$15M |
|
39
Solid Biosciences
SLDB
$900M
| $6.72M | 0.21% |
1,418,439
| – | – |
|
40
SkinHealth Systems
SKIN
$85.7M
| $6.32M | 0.19% |
+500,000
| New | +$5.78M |
|
|
CANO
41
DELISTED
Cano Health, Inc.
CANO
| $3.64M | 0.11% |
40,000
| – | – |
|
42
Enanta Pharmaceuticals
ENTA
$400M
| – | – |
-110,000
| Closed | -$5.12M |
|
43
Qiagen
QGEN
$8.72B
| – | – |
-707,292
| Closed | -$37.4M |
|
|
SAGE
44
DELISTED
Sage Therapeutics
SAGE
| – | – |
-700,000
| Closed | -$26.7M |
|
45
CALL
Viatris
VTRS
$18.9B
| – | – |
-5,000,000
| Closed | -$55.6M |
|
|
SGEN
46
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-500,000
| Closed | -$64.3M |
|
|
CSII
47
DELISTED
Cardiovascular Systems, Inc.
CSII
| – | – |
-1,300,000
| Closed | -$17.7M |
|
Similar funds
PP
SAF
NRD
FC
GIM
SC
BWA
CCP
Camber Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Camber Capital Management held 47 positions worth $3.25B, up 12% from $2.92B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Camber Capital Management deployed $192M of net new capital in Q1 2023, opening 8 new positions and adding to 9 existing holdings. Its largest new stake was Baxter International: 3,000,000 shares worth $122M.
By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 97% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Align Technology, an estimated $95.9M trimmed.
- Camber Capital Management's largest Q1 2023 buy was Baxter International: 3,000,000 shares worth $122M.
- Camber Capital Management added most to Walgreens Boots Alliance in Q1 2023, an estimated $53.2M increase.
- Camber Capital Management's biggest Q1 2023 reduction was Align Technology, cutting an estimated $95.9M.
- Camber Capital Management fully exited Seagen Inc. Common Stock in Q1 2023, selling an estimated $64.3M.
- Camber Capital Management's ten largest holdings make up 66% of its $3.25B portfolio in Q1 2023.
- Camber Capital Management opened 8 new positions and closed 6 in Q1 2023.
- Camber Capital Management's portfolio value rose 12% quarter-over-quarter to $3.25B.
Based on Camber Capital Management's 13F filing for Q1 2023, filed 15 May 2023.